---
figid: PMC8971815__fimmu-13-835005-g002
figtitle: Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal
  Stem Cell Therapy
organisms:
- Escherichia coli
- Salmonella enterica subsp. enterica serovar Typhimurium
- Lactococcus lactis
- Lactobacillus acidophilus
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Drosophila melanogaster
- Sus scrofa
- Cinnamomum verum
- Melia azedarach
- Schistosoma japonicum
- Homo sapiens
- gut metagenome
pmcid: PMC8971815
filename: fimmu-13-835005-g002.jpg
figlink: /pmc/articles/PMC8971815/figure/f2/
number: F2
caption: TGF-β activated signaling pathway in intestinal fibrosis. TGF-β promotes
  fibrosis by regulating related cells through the activation of the canonical Smad
  signaling pathway and noncanonical pathway including MAPK and WNT, which contribute
  to the development of EMT in epithelial cells, the proliferation of fibroblasts,
  and transformation of fibroblasts and smooth muscle cells to myofibroblasts. In
  effect, ECM is overexpressed, resulting in increased collagen deposition. TGF-β,
  transforming growth factor β; Smad, drosophila mothers against decapentaplegic;
  Ras, rat sarcoma; MEK, methyl ethyl ketone; ERK, extracellular regulated protein
  kinases; GSK3β, glycogen synthase kinase3β.
papertitle: Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of
  Mesenchymal Stem Cell Therapy.
reftext: Yifei Wang, et al. Front Immunol. 2022;13:835005.
year: '2022'
doi: 10.3389/fimmu.2022.835005
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: intestinal fibrosis | IBD | mechanism | MSC | therapy | immune cells
automl_pathway: 0.9478456
figid_alias: PMC8971815__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Sus scrofa
- Bos taurus
redirect_from: /figures/PMC8971815__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8971815__fimmu-13-835005-g002.html
  '@type': Dataset
  description: TGF-β activated signaling pathway in intestinal fibrosis. TGF-β promotes
    fibrosis by regulating related cells through the activation of the canonical Smad
    signaling pathway and noncanonical pathway including MAPK and WNT, which contribute
    to the development of EMT in epithelial cells, the proliferation of fibroblasts,
    and transformation of fibroblasts and smooth muscle cells to myofibroblasts. In
    effect, ECM is overexpressed, resulting in increased collagen deposition. TGF-β,
    transforming growth factor β; Smad, drosophila mothers against decapentaplegic;
    Ras, rat sarcoma; MEK, methyl ethyl ketone; ERK, extracellular regulated protein
    kinases; GSK3β, glycogen synthase kinase3β.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ctnnb1
  - Akt1
  - Gsk3b
  - Tgfb1
  - Ltbp1
  - ras
  - Hras
  - Kras
  - Rem1
  - Smad7
  - Akt2
  - Map2k1
  - Mapk3
  - Mapk1
  - Smad3
  - Smad2
  - Smad4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - AKT1
  - GSK3B
  - TGFB1
  - TGFB2
  - TGFB3
  - KRAS
  - HRAS
  - NRAS
  - SMAD7
  - AKT2
  - MAP2K1
  - MAPK3
  - MAPK1
  - SMAD3
  - SMAD2
  - SMAD4
  - Wnt2
---
